Jaypirca (pirtobrutinib) — Medica
Richter’s transformation to diffuse large B-cell lymphoma
Initial criteria
- Patient is age ≥ 18 years
- Patient meets ONE of the following: has tried at least one chemotherapy regimen OR is not a candidate for a chemotherapy regimen
Approval duration
1 year